| 摘要 |
610715 , Disclosed are compounds of formula (I) which are selected from the group consisting of: 3-(indan-4-yl)-propenoylguanidine, 3-(indan-5-yl)-propenoylguanidine and 2,3-methylenedioxycinnamoyl guanidine and pharmaceutically acceptable salts thereof. Further disclosed is a pharmaceutical composition comprising a compound selected 3-(indan-4-yl)-propenoylguanidine, 3-(indan-5-yl)-propenoylguanidine or 2,3-methylenedioxycinnamoyl guanidine, optionally in combination with one or more pharmaceutical acceptable carriers or adjuvants, for the therapeutic or prophylactic treatment of a subject exposed to or infected by a virus (such as Hepatitis C virus (HCV), Human Immunodeficiency Virus (HIV), and Dengue virus). |
